These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 2494183)

  • 21. Mechanism of Trypanosoma brucei gambiense (group 1) resistance to human trypanosome lytic factor.
    Kieft R; Capewell P; Turner CM; Veitch NJ; MacLeod A; Hajduk S
    Proc Natl Acad Sci U S A; 2010 Sep; 107(37):16137-41. PubMed ID: 20805508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Developmentally regulated sensitivity of Trypanosoma brucei brucei to the cytotoxic effects of human high-density lipoprotein.
    Moore DR; Smith A; Hager KM; Waldon R; Esko JD; Hajduk SL
    Exp Parasitol; 1995 Sep; 81(2):216-26. PubMed ID: 7556564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Haptoglobin-related protein mediates trypanosome lytic factor binding to trypanosomes.
    Drain J; Bishop JR; Hajduk SL
    J Biol Chem; 2001 Aug; 276(32):30254-60. PubMed ID: 11352898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of phospholipids in the cytotoxic action of high density lipoprotein on trypanosomes.
    Rifkin MR
    J Lipid Res; 1991 Apr; 32(4):639-47. PubMed ID: 1856609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The human trypanolytic factor: a drug shaped naturally.
    Vanhamme L
    Infect Disord Drug Targets; 2010 Aug; 10(4):266-82. PubMed ID: 20429865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trypanosoma brucei brucei: differences in the trypanocidal activity of human plasma and its relationship to the level of high density lipoproteins.
    Gillett MP; Owen JS
    Trans R Soc Trop Med Hyg; 1991; 85(5):612-6. PubMed ID: 1780989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. APOL1 expression is induced by Trypanosoma brucei gambiense infection but is not associated with differential susceptibility to sleeping sickness.
    Ilboudo H; Berthier D; Camara M; Camara O; Kabore J; Leno M; Keletigui S; Chantal I; Jamonneau V; Belem AM; Cuny G; Bucheton B
    Infect Genet Evol; 2012 Oct; 12(7):1519-23. PubMed ID: 22691369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of DNA hybridization and numerical taxonomy in determining relationships between Trypanosoma brucei stocks and subspecies.
    Paindavoine P; Pays E; Laurent M; Geltmeyer Y; Le Ray D; Mehlitz D; Steinert M
    Parasitology; 1986 Feb; 92 ( Pt 1)():31-50. PubMed ID: 3960593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum resistance-associated protein blocks lysosomal targeting of trypanosome lytic factor in Trypanosoma brucei.
    Oli MW; Cotlin LF; Shiflett AM; Hajduk SL
    Eukaryot Cell; 2006 Jan; 5(1):132-9. PubMed ID: 16400175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Molecular dialogue between African trypanosomes and humans].
    Pays E
    Bull Mem Acad R Med Belg; 2011; 166(10-12):358-63; discussion 364-5. PubMed ID: 23082501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of the binding of human and bovine high-density lipoproteins by bloodstream forms of the African trypanosome, Trypanosoma brucei brucei.
    Gillett MP; Owen JS
    Biochim Biophys Acta; 1992 Feb; 1123(3):239-48. PubMed ID: 1536861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A co-evolutionary arms race: trypanosomes shaping the human genome, humans shaping the trypanosome genome.
    Capewell P; Cooper A; Clucas C; Weir W; Macleod A
    Parasitology; 2015 Feb; 142 Suppl 1(Suppl 1):S108-19. PubMed ID: 25656360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of action of gemfibrozil on lipoprotein metabolism.
    Saku K; Gartside PS; Hynd BA; Kashyap ML
    J Clin Invest; 1985 May; 75(5):1702-12. PubMed ID: 3923042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The main lytic factor of Trypanosoma brucei brucei in normal human serum is not high density lipoprotein.
    Raper J; Nussenzweig V; Tomlinson S
    J Exp Med; 1996 Mar; 183(3):1023-9. PubMed ID: 8642243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences between Trypanosoma brucei gambiense groups 1 and 2 in their resistance to killing by trypanolytic factor 1.
    Capewell P; Veitch NJ; Turner CM; Raper J; Berriman M; Hajduk SL; MacLeod A
    PLoS Negl Trop Dis; 2011 Sep; 5(9):e1287. PubMed ID: 21909441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct Proteomic Signatures in 16 HDL (High-Density Lipoprotein) Subspecies.
    Furtado JD; Yamamoto R; Melchior JT; Andraski AB; Gamez-Guerrero M; Mulcahy P; He Z; Cai T; Davidson WS; Sacks FM
    Arterioscler Thromb Vasc Biol; 2018 Dec; 38(12):2827-2842. PubMed ID: 30571168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Human resistance to African trypanosoma infections].
    Perez-Morga D
    Bull Mem Acad R Med Belg; 2007; 162(7-9):381-6; discussion 386. PubMed ID: 18429487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemotherapeutic strategies against Trypanosoma brucei: drug targets vs. drug targeting.
    Lüscher A; de Koning HP; Mäser P
    Curr Pharm Des; 2007; 13(6):555-67. PubMed ID: 17346174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transgenic mice expressing human apolipoprotein A-I have sera with modest trypanolytic activity in vitro but remain susceptible to infection by Trypanosoma brucei brucei.
    Owen JS; Gillett MP; Hughes TE
    J Lipid Res; 1992 Nov; 33(11):1639-46. PubMed ID: 1464747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of high-density lipoprotein with Trypanosoma brucei: effect of membrane stabilizers.
    Rifkin MR
    J Cell Biochem; 1983; 23(1-4):57-70. PubMed ID: 6327740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.